
| 3 min read
In vivo studies of the antibiotic darobactin D22 against high-priority gram-negative bacteria show promise for further drug development.
| 4 min read
Pfizer researchers are developing new treatments to target breast cancer tumors that flourish in the presence of hormones.
| 4 min read
The protein APLP1 strongly associates with brain-derived EVs. A blood test could one day isolate these molecular packets to diagnose neurological disorders.
| 6 min read
Enzyme replacement therapy has been the mainstay of Pompe disease. New and emerging therapies may provide more options for patients.News
Cancer Research News
Editor's Pick
Multimedia


Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored


Latest IssueVolume 20 • Issue 6 • November 2024
November 2024
November 2024 Issue
Explore this issue